What specific supplements did Dr. Sanjay Gupta list for cognitive decline prevention in 2024?

1. Omega‑3 fatty acids (fish oil): the most consistently cited supplement

Across reporting in 2024, Dr. Gupta points to omega‑3 fatty acids as the principal supplement he and colleagues discuss for brain health, often framing them as a complement to diet rather than a magic bullet; coverage notes he was advised to take an omega‑3 fish‑oil preparation and that researchers are investigating whether high‑dose omega‑3 can help some genetically at‑risk groups maintain brain levels of these fats ^{[1] [2]}. That caveat—preference for getting omega‑3s from food like cold‑water fish—appears in Gupta’s own public advice and in the reporting citing him ^{[2] [4]}. Reporting also flags practical concerns about supplement quality, noting investigations that found many fish‑oil products rancid, a point Gupta’s coverage references when discussing real‑world supplementation ^[1].

2. Curcumin (bioavailable forms such as Theracurmin): singled out in his book and commentary

Gupta has highlighted curcumin research in the context of brain health and has specifically referred to highly bioavailable formulations—Theracurmin is mentioned in articles summarizing his recommendations—because standard curcumin is poorly absorbed and studies use enhanced preparations ^[3]. Sources tie that recommendation to the evidence base he cites in his book Keep Sharp and public commentary, where he frames curcumin as a researched compound rather than a proven preventive cure for dementia ^[3]. The coverage promotes scrutiny of formulation and dosage, reflecting Gupta’s emphasis on evidence and quality when supplements are considered ^[3].

3. Skepticism toward routine multivitamins and “brain‑boosting” pills

Gupta’s reporting repeatedly cautions that many popular “brain‑boosting” supplements lack robust evidence for preventing cognitive decline; he references large studies showing no clear benefit from routine multivitamin/mineral use in otherwise non‑deficient adults and urges lifestyle measures over pills ^[4]. This skepticism is not incidental—his public messaging, as reported, consistently prioritizes the SHARP dietary protocol and lifestyle interventions (exercise, sleep, mental engagement) and reserves supplements for targeted use or research contexts ^{[4] [5]}.

4. How he frames supplements within a broader prevention strategy

When Dr. Gupta discusses supplements in 2024 coverage, it’s within a broader prevention playbook: diet (S.H.A.R.P.), exercise, sleep, cognitive engagement, and clinical risk‑factor control take precedence, and supplements are described as adjuncts—sometimes clinically suggested for individuals with specific risk profiles (for example, APOE4 carriers in omega‑3 research)—rather than universal prescriptions ^{[4] [2] [5]}. Sources indicate Gupta relays the nuance that ongoing trials may change recommendations for certain subgroups, but the current public counsel stresses whole foods and proven lifestyle changes first ^[2].

5. Limits of available reporting and unanswered questions

The sources available name omega‑3 (fish oil) and bioavailable curcumin (Theracurmin) as the explicit supplements Gupta discussed in the 2024 coverage and repeatedly show his broader caution about supplement hype ^{[1] [3] [4]}. There is no comprehensive 2024 list in these sources that expands beyond those items, so it cannot be asserted from the provided reporting that Gupta endorsed additional specific supplements that year; any definitive catalog beyond what’s cited would require more direct sourcing from Gupta’s 2024 appearances, interviews, or his book excerpts published that year ^{[1] [3] [4]}.